» Articles » PMID: 25390893

Iron Overload and Apoptosis of HL-1 Cardiomyocytes: Effects of Calcium Channel Blockade

Overview
Journal PLoS One
Date 2014 Nov 13
PMID 25390893
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Iron overload cardiomyopathy that prevails in some forms of hemosiderosis is caused by excessive deposition of iron into the heart tissue and ensuing damage caused by a raise in labile cell iron. The underlying mechanisms of iron uptake into cardiomyocytes in iron overload condition are still under investigation. Both L-type calcium channels (LTCC) and T-type calcium channels (TTCC) have been proposed to be the main portals of non-transferrinic iron into heart cells, but controversies remain. Here, we investigated the roles of LTCC and TTCC as mediators of cardiac iron overload and cellular damage by using specific Calcium channel blockers as potential suppressors of labile Fe(II) and Fe(III) ingress in cultured cardiomyocytes and ensuing apoptosis.

Methods: Fe(II) and Fe(III) uptake was assessed by exposing HL-1 cardiomyocytes to iron sources and quantitative real-time fluorescence imaging of cytosolic labile iron with the fluorescent iron sensor calcein while iron-induced apoptosis was quantitatively measured by flow cytometry analysis with Annexin V. The role of calcium channels as routes of iron uptake was assessed by cell pretreatment with specific blockers of LTCC and TTCC.

Results: Iron entered HL-1 cardiomyocytes in a time- and dose-dependent manner and induced cardiac apoptosis via mitochondria-mediated caspase-3 dependent pathways. Blockade of LTCC but not of TTCC demonstrably inhibited the uptake of ferric but not of ferrous iron. However, neither channel blocker conferred cardiomyocytes with protection from iron-induced apoptosis.

Conclusion: Our study implicates LTCC as major mediators of Fe(III) uptake into cardiomyocytes exposed to ferric salts but not necessarily as contributors to ensuing apoptosis. Thus, to the extent that apoptosis can be considered a biological indicator of damage, the etiopathology of cardiosiderotic damage that accompanies some forms of hemosiderosis would seem to be unrelated to LTCC or TTCC, but rather to other routes of iron ingress present in heart cells.

Citing Articles

Characterization of iron status biomarkers and hematological indices among young adults of East Asian or Northern European ancestry: A cross-sectional analysis from the Iron Genes in East Asian and Northern European Adults Study (FeGenes).

Barad A, Xu Y, Bender E, Kang W, Xu R, Gu Z Am J Clin Nutr. 2025; 121(2):394-405.

PMID: 39909709 PMC: 11863323. DOI: 10.1016/j.ajcnut.2024.10.014.


Metal ions overloading and cell death.

Lai Y, Gao F, Ge R, Liu R, Ma S, Liu X Cell Biol Toxicol. 2024; 40(1):72.

PMID: 39162885 PMC: 11335907. DOI: 10.1007/s10565-024-09910-4.


Importance of Autophagy in Mediating Cellular Responses to Iron Overload in Cardiomyocytes.

Tam E, Reno C, Nguyen K, Cho S, Sweeney G Rev Cardiovasc Med. 2024; 23(5):167.

PMID: 39077594 PMC: 11273664. DOI: 10.31083/j.rcm2305167.


.

Miao S, Yang L, Xu T, Liu Z, Zhang Y, Ding L MedComm (2020). 2024; 5(6):e571.

PMID: 38840772 PMC: 11151151. DOI: 10.1002/mco2.571.


Mitochondria-mediated Ferroptosis in Diseases Therapy: From Molecular Mechanisms to Implications.

Feng F, He S, Li X, He J, Luo L Aging Dis. 2023; 15(2):714-738.

PMID: 37548939 PMC: 10917537. DOI: 10.14336/AD.2023.0717.


References
1.
Kumfu S, Chattipakorn S, Srichairatanakool S, Settakorn J, Fucharoen S, Chattipakorn N . T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice. Eur J Haematol. 2010; 86(2):156-66. DOI: 10.1111/j.1600-0609.2010.01549.x. View

2.
Horwitz L, Rosenthal E . Iron-mediated cardiovascular injury. Vasc Med. 1999; 4(2):93-9. DOI: 10.1177/1358836X9900400207. View

3.
White S, Constantin P, Claycomb W . Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol. 2004; 286(3):H823-9. DOI: 10.1152/ajpheart.00986.2003. View

4.
Gujja P, Rosing D, Tripodi D, Shizukuda Y . Iron overload cardiomyopathy: better understanding of an increasing disorder. J Am Coll Cardiol. 2010; 56(13):1001-12. PMC: 2947953. DOI: 10.1016/j.jacc.2010.03.083. View

5.
Esposito B, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik Z . Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood. 2003; 102(7):2670-7. DOI: 10.1182/blood-2003-03-0807. View